Vetera WNV Single Dose
Boehringer Ingelheim - Vetera West Nile Virus Horse Vaccine is for the vaccination of healthy horses 4 months age and older, including pregnant mares.
Boehringer Ingelheim Vetera West Nile Virus Horse Vaccine is for the vaccination of healthy horses 4 months age and older, including pregnant mares. Provides 12 months duration of immunity against West Nile virus. Contains contemporary WNV strains, offering the most up-to-date protection. Formulated with a unique purification process and adjuvant formulation to trigger a healthy immune response and minimize vaccine reactions.
FEATURES / BENEFITS
Provides at least 12 months duration of immunity against WNV.
Safe for use in horses as young as 4 months of age.
Safe for use in pregnant mares.
Contains equine origin 2005 West Nile virus isolate (E159) strain.
Store at 35 to 45 °F (2 to 7 °C); protect from freezing.
Do not vaccinate within 21 days before slaughter.
Use entire contents when first opened.
Anaphylactoid reactions may occur following use. Antidote: Epinephrine.
Shake product well before use. Using aseptic technique, inoculate horses intramuscularly with a 1-ml dose. Administer a second 1-ml dose intramuscularly in 3 to 4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1-ml intramuscular dose.